Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000904454-15-000087
Filing Date
2015-02-11
Accepted
2015-02-11 14:26:42
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G/A FOR BIOSPECIFICS TECHNOLOGIES BY ABDIEL QUALIFIED MASTER FUND LP s13ga_012315-biospfstechcorp.htm SC 13G/A 115133
  Complete submission text file 0000904454-15-000087.txt   116579
Mailing Address 35 WILBUR STREET LYNBROOK NY 11563
Business Address 35 WILBUR ST LYNBROOK NY 11563 5165937000
BIOSPECIFICS TECHNOLOGIES CORP (Subject) CIK: 0000875622 (see all company filings)

EIN.: 113054851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-79091 | Film No.: 15598858
SIC: 2834 Pharmaceutical Preparations

Mailing Address 89 NEXUS WAY CAMANA BAY E9 KY1-9007
Business Address 410 PARK AVENUE SUITE 530 NEW YORK NY 10022 646-496-9351
Abdiel Qualified Master Fund LP (Filed by) CIK: 0001508239 (see all company filings)

EIN.: 208096029 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G/A